← Leaderboards
Delisa Fairweather
Johns Hopkins University
$8,445,799
Attributed
$9,145,283
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,145,283 · 8
By mechanism
R01$7,030,009 · 3
R21$2,115,274 · 5
Top collaborators
- Jon Sin2 shared
- Joy Wolfram2 shared
- Katelyn Ann Bruno1 shared
- Dacre Knight1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Mehran Armand$9,641,501
- Charles J Lowenstein$14,170,963
- Daniela Cihakova$6,954,631
- Hana Bleicher Minsky$54,538
Others in their field
Top investigators on “Male”
- Myron E Essex · Harvard University (Sch Of Public Hlth)$47,217,905
- Kc Kent Lloyd · University Of California At Davis$33,183,422
- Linda A Teplin · Northwestern University$32,082,912
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
- Edie C Goldsmith · University Of South Carolina At Columbia$30,062,912
- Kevin A. Pelphrey · University Of California Los Angeles$29,809,496
Research focus
MaleInflammationMyocarditisHeartIncidenceCoxsackie VirusesSeveritiesAcuteMediatingCellsDilated CardiomyopathyFemaleImmune ResponseViralInflammatoryVirus DiseasesVirusInfectionMacrophageWomanSignal TransductionTlr4 GeneHeart FailureCardiac
Grant awards (29)
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex$721,646
R01 · FY2025 · HL · contact PI
Sex differences in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders$379,148
R21 · FY2025 · AR · contact PI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex$710,444
R01 · FY2024 · HL · contact PI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex$24,414
R01 · FY2024 · HL · contact PI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex$742,061
R01 · FY2023 · HL · contact PI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex$24,414
R01 · FY2023 · HL · contact PI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex$747,061
R01 · FY2022 · HL · contact PI
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)$195,625
R21 · FY2021 · AI · contact PI
Sex differences in exercise-induced mitochondrial function during viral myocarditis$113,606
R21 · FY2021 · AI · contact PI
Sex differences in exercise-induced mitochondrial function during viral myocarditis$289,409
R21 · FY2020 · AI · contact PI
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)$234,750
R21 · FY2020 · AI · contact PI
Role of viral mitophagosomes in driving sex differences in myocarditis$122,438
R21 · FY2020 · AI · contact PI
Role of viral mitophagosomes in driving sex differences in myocarditis$340,625
R21 · FY2019 · AI · contact PI
Sex Differences in Complement during Myocarditis/DCM$265,120
R01 · FY2015 · HL · contact PI
Endocrine disruptors effect on inflammatory heart disease$165,785
R21 · FY2015 · ES · contact PI
Sex Differences in Complement during Myocarditis/DCM$133,805
R01 · FY2015 · HL · contact PI
Endocrine disruptors effect on inflammatory heart disease$30,888
R21 · FY2015 · ES · contact PI
Sex Differences in Complement during Myocarditis/DCM$396,900
R01 · FY2014 · HL · contact PI
Endocrine disruptors effect on inflammatory heart disease$243,000
R21 · FY2014 · ES · contact PI
Sex Differences in Complement during Myocarditis/DCM$385,560
R01 · FY2013 · HL · contact PI
Sex Differences in Complement during Myocarditis/DCM$405,000
R01 · FY2012 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$482,308
R01 · FY2011 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$468,573
R01 · FY2010 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$12,136
R01 · FY2010 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$410,000
R01 · FY2009 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$252,791
R01 · FY2009 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$28,505
R01 · FY2009 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$410,000
R01 · FY2008 · HL · contact PI
Regulating heart disease: the adjuvant effect of viral infection.$409,271
R01 · FY2007 · HL · contact PI